{"id":"W3006072911","doi":"10.1007/s10637-020-00909-2","title":"Evaluating the antitumor activity of sphingosine-1-phosphate against human triple-negative breast cancer cells with basal-like morphology","year":2020,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Saskatchewan","funders":"University of Saskatchewan","keywords":"Apoptosis; Sphingosine; Cell culture; Triple-negative breast cancer; Cytotoxicity; Paclitaxel; Sphingolipid; Sphingosine-1-phosphate; Cancer research; Cell growth; Biology; Cell; Breast cancer; Docetaxel; Doxorubicin; Cancer; Chemotherapy; Internal medicine; Medicine; Cell biology; In vitro; Receptor; Biochemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002734906,0.0002109612,0.0002441989,0.0000277864,0.0001851622,0.00002794513,0.0002797979,0.00008305049,0.00006039497],"category_scores_gemma":[0.0001020189,0.0001564943,0.00008381632,0.0002374728,0.0003361474,0.00001786589,0.0001017122,0.0001755544,0.000004443585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001403496,"about_ca_system_score_gemma":0.0005543209,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000567038,"about_ca_topic_score_gemma":0.00002483866,"domain_scores_codex":[0.9986132,0.0001320253,0.0002715569,0.0004128875,0.0003388576,0.0002314401],"domain_scores_gemma":[0.9990263,0.00005650034,0.0003137719,0.0002197874,0.0001980795,0.0001855886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002127956,0.00002338634,0.001197319,0.00002224111,0.00008611164,0.000001847164,0.0006014136,0.00698238,0.9881237,0.0001954499,0.001772697,0.0007806696],"study_design_scores_gemma":[0.00161111,0.0001628058,0.01107268,0.0000522645,0.00005400543,0.000006381858,0.00009844665,0.00200163,0.984,0.0002604159,0.0004456876,0.0002346067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951588,0.0002857659,0.0003937015,0.003451571,0.0001623275,0.0002844656,0.0001177832,0.00001524693,0.0001303604],"genre_scores_gemma":[0.9922,0.00005262503,0.001906962,0.00479082,0.0007626521,0.00002540371,0.00006546913,0.00003023096,0.0001658843],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009875361,"threshold_uncertainty_score":0.6381653,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03565899534497211,"score_gpt":0.3024794356762254,"score_spread":0.2668204403312532,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}